{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:16:40Z","timestamp":1792819000741,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.jfo.2012.12.004","type":"journal-article","created":{"date-parts":[[2013,5,18]],"date-time":"2013-05-18T04:17:05Z","timestamp":1368850625000},"page":"526-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Ocular manifestations of the potentially lethal rheumatologic and vasculitic disorders"],"prefix":"10.1016","volume":"36","author":[{"given":"C. Stephen","family":"Foster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2012.12.004_bib0005","first-page":"1161","article-title":"Rheumatoid scleritis: a long-term follow-up","volume":"66","author":"Jones","year":"1973","journal-title":"Proc Soc Med"},{"key":"10.1016\/j.jfo.2012.12.004_bib0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/ard.48.1.7","article-title":"Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study","volume":"48","author":"Erhardt","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jfo.2012.12.004_bib0015","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0161-6420(84)34160-4","article-title":"Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of immunosuppression","volume":"91","author":"Foster","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2012.12.004_bib0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000306825","article-title":"Combined treatment of scleromalacia perforans in rheumatoid arthritis with penicillamine and plastic surgery","volume":"166","author":"Zer","year":"1973","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jfo.2012.12.004_bib0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0002-9394(14)76823-0","article-title":"Therapy of scleritis with cytotoxic agents","volume":"86","author":"Jampol","year":"1978","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2012.12.004_bib0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1076\/ocii.11.2.141.15915","article-title":"Successful treatment with combination of systemic antiviral drug and intravitreal ganciclovir injections in the management of severe necrotizing herpetic retinitis","volume":"11","author":"Chau Tran","year":"2003","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2012.12.004_bib0035","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1001\/archinte.1985.00360080161024","article-title":"The use of high-dose pulse methylprednisolone in rheumatoid arthritis: unproved theory","volume":"145","author":"Barry","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jfo.2012.12.004_bib0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/03009748109095288","article-title":"High dose intravenous methylprednisolone (pulse therapy) in the treatment of rheumatoid diseas","volume":"10","author":"Williams","year":"1981","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jfo.2012.12.004_bib0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0140-6736(82)90323-3","article-title":"A double-blind placebo-controlled trial of methylprednisolone pulse therapy in active rheumatoid disease","volume":"2","author":"Williams","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.jfo.2012.12.004_bib0050","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0161-6420(80)35177-4","article-title":"The diagnosis and management of scleritis","volume":"87","author":"Watson","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2012.12.004_bib0055","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/art.1780310904","article-title":"Lupus Retinopathy Patterns associations, and prognosis","volume":"31","author":"Stafford-Brady","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfo.2012.12.004_bib0060","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/archopht.1986.01050160114025","article-title":"Severe retinal vaso-occlusive disease in systemic lupus erythematous","volume":"4","author":"Jabs","year":"1986","journal-title":"Arch Opthalmol"},{"key":"10.1016\/j.jfo.2012.12.004_bib0065","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0002-9394(81)90779-0","article-title":"Visual loss as the initial symptom of systemic lupus erythematosus","volume":"2","author":"Wong","year":"1981","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2012.12.004_bib0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0002-9343(67)90144-1","article-title":"Long-term follow-up study of periarteritis nodosa","volume":"43","author":"Fronert","year":"1967","journal-title":"Am J Med"},{"key":"10.1016\/j.jfo.2012.12.004_bib0075","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1136\/bmj.1.5183.1399","article-title":"Treatment of polyarteritis nodosa with cortisone; results after three years. Report to the Medical Research Counsel by the Collagen Diseases and Hypersensitivity Panel","volume":"1","author":"Pickering","year":"1960","journal-title":"Br Med J"},{"key":"10.1016\/j.jfo.2012.12.004_bib0080","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/0002-9343(78)90533-8","article-title":"Cyclophosphamide-induced remissions in advanced polyarteritis nodosa","volume":"64","author":"Fauci","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.jfo.2012.12.004_bib0085","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0002-9343(79)90634-X","article-title":"Immunosuppressive and corticosteroid therapy for polyarteritis nodosa","volume":"67","author":"Lieb","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.jfo.2012.12.004_bib0090","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551213001125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551213001125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:03:15Z","timestamp":1759258995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551213001125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0181551213001125"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2012.12.004","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular manifestations of the potentially lethal rheumatologic and vasculitic disorders","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2012.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}